Menu
×
West Ashley Library
9 a.m. - 5 p.m.
Phone: (843) 766-6635
Wando Mount Pleasant Library
9 a.m. - 5 p.m.
Phone: (843) 805-6888
Village Library
9 a.m. - 1 p.m.
Phone: (843) 884-9741
St. Paul's/Hollywood Library
9 a.m. - 5 p.m.
Phone: (843) 889-3300
Otranto Road Library
9 a.m. - 5 p.m.
Phone: (843) 572-4094
Mt. Pleasant Library
9 a.m. – 5 p.m.
Phone: (843) 849-6161
McClellanville Library
9 a.m. – 1 p.m.
Phone: (843) 887-3699
Keith Summey North Charleston Library
9 a.m. - 5 p.m.
Phone: (843) 744-2489
John's Island Library
9 a.m. - 5 p.m.
Phone: (843) 559-1945
Hurd/St. Andrews Library
9 a.m. - 5 p.m.
Phone: (843) 766-2546
Folly Beach Library
9 a.m. - 2 p.m.
*open the 2nd and 4th Saturday
*open the 2nd and 4th Saturday
Phone: (843) 588-2001
Dorchester Road Library
9 a.m. - 5 p.m.
Phone: (843) 552-6466
John L. Dart Library
9 a.m. - 5 p.m.
Phone: (843) 722-7550
Bees Ferry West Ashley Library
9 a.m. - 5 p.m.
Phone: (843) 805-6892
Baxter-Patrick James Island
9 a.m. - 5 p.m.
Phone: (843) 795-6679
Miss Jane's Building (Edisto Library Temporary Location)
Closed
Phone: (843) 869-2355
Edgar Allan Poe/Sullivan's Island Library
Closed for renovations
Phone: (843) 883-3914
Main Library
9 a.m. - 5 p.m.
Phone: (843) 805-6930
Mobile Library
Closed
Phone: (843) 805-6909
Today's Hours
West Ashley Library
9 a.m. - 5 p.m.
Phone: (843) 766-6635
Wando Mount Pleasant Library
9 a.m. - 5 p.m.
Phone: (843) 805-6888
Village Library
9 a.m. - 1 p.m.
Phone: (843) 884-9741
St. Paul's/Hollywood Library
9 a.m. - 5 p.m.
Phone: (843) 889-3300
Otranto Road Library
9 a.m. - 5 p.m.
Phone: (843) 572-4094
Mt. Pleasant Library
9 a.m. – 5 p.m.
Phone: (843) 849-6161
McClellanville Library
9 a.m. – 1 p.m.
Phone: (843) 887-3699
Keith Summey North Charleston Library
9 a.m. - 5 p.m.
Phone: (843) 744-2489
John's Island Library
9 a.m. - 5 p.m.
Phone: (843) 559-1945
Hurd/St. Andrews Library
9 a.m. - 5 p.m.
Phone: (843) 766-2546
Folly Beach Library
9 a.m. - 2 p.m.
*open the 2nd and 4th Saturday
*open the 2nd and 4th Saturday
Phone: (843) 588-2001
Dorchester Road Library
9 a.m. - 5 p.m.
Phone: (843) 552-6466
John L. Dart Library
9 a.m. - 5 p.m.
Phone: (843) 722-7550
Bees Ferry West Ashley Library
9 a.m. - 5 p.m.
Phone: (843) 805-6892
Baxter-Patrick James Island
9 a.m. - 5 p.m.
Phone: (843) 795-6679
Miss Jane's Building (Edisto Library Temporary Location)
Closed
Phone: (843) 869-2355
Edgar Allan Poe/Sullivan's Island Library
Closed for renovations
Phone: (843) 883-3914
Main Library
9 a.m. - 5 p.m.
Phone: (843) 805-6930
Mobile Library
Closed
Phone: (843) 805-6909
Patron Login
menu
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Neue Aspekte der medikamentösen Nephroprotektion. (German)
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Beimler, Jörg
- Source:
Der Internist; Nov2022, Vol. 63 Issue 11, p1200-1207, 8p - Source:
- Additional Information
- Alternate Title: New aspects of pharmacological nephroprotection. (English)
- Abstract: Current estimates forecast that chronic kidney diseases will be the fifth most common cause of death worldwide by 2040. The prevalence of chronic renal diseases increases with age and, in many countries, affects patients with overweight, diabetes and hypertension. The primary objective of the treatment of chronic renal diseases is the delay of disease progression. Established markers for the deterioration of renal function include glomerular filtration rate and albuminuria. Pharmacological blockade of the renin-angiotensin-aldosterone system (RAAS) by angiotensin-converting enzyme inhibitors (ACE) or angiotensin receptor blockers (ARB) represents the cornerstone of drug-related nephroprotection. Current Kidney Disease: Improving Global Outcomes (KDIGO) guidelines recommend the use of ACEI or ARB for diabetic and non-diabetic patients with moderate and heavy albuminuria. In recent years, sodium–glucose linked transporter 2 inhibitors (SGLT-2) have been established in the field of cardio- and nephroprotection. Their protective effects occur regardless of blood sugar reduction. Current data suggest that the use of SGLT‑2 inhibitors will soon be part of therapy in non-diabetic kidney disease. One of the first drugs in this substance class, dapagliflozin, is already approved in Germany for the treatment of chronic renal diseases in adults with and without type 2 diabetes. [ABSTRACT FROM AUTHOR]
- Abstract: Zusammenfassung: Aktuelle Schätzungen lassen erwarten, dass chronische Nierenerkrankungen bis 2040 die fünfthäufigste Todesursache weltweit darstellen werden. Die Prävalenz chronischer Nierenerkrankungen steigt mit zunehmendem Alter an und betrifft in vielen Ländern vor allem Patient:innen mit Übergewicht, Diabetes und Bluthochdruck. Das primäre Ziel der Behandlung chronischer Nierenerkrankungen liegt in der Progressionsverzögerung der Erkrankung. Etablierte Marker für die Progression einer Nierenfunktionseinschränkung sind die glomeruläre Filtrationsrate und die Albuminurie. Die pharmakologische Blockade des Renin-Angiotensin-Aldosteron-Systems (RAAS) durch Angiotensin-converting-enzyme-Inhibitoren (ACEI) bzw. Angiotensinrezeptorblocker (ARB) ist seit vielen Jahren der Eckpfeiler einer medikamentösen renalen Progressionsverzögerung. Die aktuellen Leitlinien von Kidney Disease: Improving Global Outcomes (KDIGO) empfehlen für diabetische und nichtdiabetische Patient:innen mit moderater oder schwerer Albuminurie den Einsatz eines ACEI oder ARB. In den letzten Jahren hat sich die Medikamentenklasse der sogenannten „sodium-glucose linked transporter 2 inhibitors" (SGLT-2-Inhibitoren) im Bereich der Kardio- bzw. Nephroprotektion etabliert. Deren protektive Effekte treten unabhängig von der Blutzuckersenkung auf. Aktuelle Daten lassen vermuten, dass der Einsatz der SGLT-2-Inhibitoren auch Eingang in die Empfehlungen zur Therapie nichtdiabetischer Nierenerkrankungen finden wird. Ein erster Vertreter dieser Substanzklasse, Dapagliflozin, ist bereits in Deutschland zur Behandlung chronischer Nierenerkrankungen bei Erwachsenen mit und ohne Diabetes mellitus Typ 2 zugelassen. [ABSTRACT FROM AUTHOR]
- Abstract: Copyright of Der Internist is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Alternate Title:
Contact CCPL
Copyright 2022 Charleston County Public Library Powered By EBSCO Stacks 3.3.0 [350.3] | Staff Login
No Comments.